Candel Therapeutics (CADL) Shares Outstanding (Weighted Average): 2020-2023
Historic Shares Outstanding (Weighted Average) for Candel Therapeutics (CADL) over the last 3 years, with Dec 2023 value amounting to $28.9 million.
- Candel Therapeutics' Shares Outstanding (Weighted Average) rose 0.09% to $28.9 million in Q4 2023 from the same period last year, while for Sep 2023 it was $28.9 million, marking a year-over-year increase of 0.10%. This contributed to the annual value of $32.5 million for FY2024, which is 12.30% up from last year.
- Per Candel Therapeutics' latest filing, its Shares Outstanding (Weighted Average) stood at $28.9 million for Q4 2023, which was down 0.00% from $28.9 million recorded in Q3 2023.
- In the past 5 years, Candel Therapeutics' Shares Outstanding (Weighted Average) registered a high of $28.9 million during Q1 2023, and its lowest value of $24.8 million during Q4 2020.
- Its 3-year average for Shares Outstanding (Weighted Average) is $28.2 million, with a median of $28.8 million in 2022.
- Data for Candel Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY grew of 15.71% (in 2022) over the last 5 years.
- Candel Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $24.8 million in 2020, then increased by 15.70% to $28.7 million in 2021, then grew by 0.71% to $28.9 million in 2022, then grew by 0.09% to $28.9 million in 2023.
- Its last three reported values are $28.9 million in Q4 2023, $28.9 million for Q3 2023, and $28.9 million during Q2 2023.